The Mena Biologics and Biosimilars Market is Estimated to Witness...

adicionou um novo artigo Outro

2023-11-16 13:25:49 -

The Mena Biologics and Biosimilars Market is Estimated to Witness High Growth owing to Increasing Uptake of Biosimilars

The Mena Biologics and Biosimilars Market is estimated to be valued at US$ 502.2 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Mena biologics and biosimilars market consists of biologic drug products primarily used for the treatment of chronic diseases like...

0 Comentários 0 Compartilhamentos 1073 Visualizações 0 Anterior